Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001610824-18-000004
Filing Date
2018-07-16
Accepted
2018-07-16 13:30:09
Documents
1
Effectiveness Date
2018-07-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14293
  Complete submission text file 0001610824-18-000004.txt   15418
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics LLC (Filer) CIK: 0001610824 (see all company filings)

EIN.: 464679590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-242888 | Film No.: 18954169